BlackRock Health Sciences Term Trust (NYSE:BMEZ) Short Interest Update

BlackRock Health Sciences Term Trust (NYSE:BMEZ) was the target of a large drop in short interest in December. As of December 31st, there was short interest totalling 48,200 shares, a drop of 61.2% from the December 15th total of 124,200 shares. Based on an average daily volume of 365,000 shares, the short-interest ratio is currently 0.1 days.

BlackRock Health Sciences Term Trust Trading Up 0.3 %

BMEZ stock opened at $15.40 on Tuesday. BlackRock Health Sciences Term Trust has a 1-year low of $14.27 and a 1-year high of $16.59. The firm has a fifty day moving average price of $15.30 and a two-hundred day moving average price of $15.58.

BlackRock Health Sciences Term Trust Announces Dividend

The business also recently declared a monthly dividend, which will be paid on Friday, January 31st. Investors of record on Wednesday, January 15th will be issued a $0.1782 dividend. This represents a $2.14 annualized dividend and a dividend yield of 13.88%. The ex-dividend date of this dividend is Wednesday, January 15th.

Insider Activity at BlackRock Health Sciences Term Trust

In other BlackRock Health Sciences Term Trust news, major shareholder Saba Capital Management, L.P. bought 29,795 shares of the business’s stock in a transaction on Wednesday, October 16th. The shares were bought at an average cost of $15.81 per share, with a total value of $471,058.95. Following the transaction, the insider now directly owns 20,750,913 shares in the company, valued at approximately $328,071,934.53. This trade represents a 0.14 % increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the stock. Penserra Capital Management LLC acquired a new position in shares of BlackRock Health Sciences Term Trust during the third quarter worth approximately $15,390,000. Almitas Capital LLC boosted its position in BlackRock Health Sciences Term Trust by 89.3% during the 2nd quarter. Almitas Capital LLC now owns 1,761,943 shares of the company’s stock worth $27,063,000 after acquiring an additional 831,025 shares during the period. Sessa Capital IM L.P. boosted its position in BlackRock Health Sciences Term Trust by 27.1% during the 2nd quarter. Sessa Capital IM L.P. now owns 1,853,022 shares of the company’s stock worth $28,462,000 after acquiring an additional 395,288 shares during the period. Sanctuary Advisors LLC bought a new position in shares of BlackRock Health Sciences Term Trust in the second quarter worth $3,179,000. Finally, Logan Stone Capital LLC acquired a new position in shares of BlackRock Health Sciences Term Trust during the second quarter valued at $1,770,000.

BlackRock Health Sciences Term Trust Company Profile

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.